{'fraction_non_alphanumeric': 0.006, 'fraction_numerical': 0.0, 'mean_word_length': 5.77027027027027, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Collaborations between academic psychiatry and the pharmaceutical industry: A perspective from industry

Abstract The author offers a perspective on the perceived conflicts of interest that influence scientific collaborations between academic psychiatry and the pharmaceutical industry. The author holds the position that the merits of a particular study should be judged based on the quality of the scientific methodology rather than on the credentials of the investigators or the source of funding.